TY - JOUR
T1 - Epidemiology of sepsis in intensive care units in Turkey
T2 - A multicenter, point-prevalence study
AU - Sepsis Study Group
AU - Baykara, Nur
AU - Akalin, Halis
AU - Arslantaş, Mustafa Kemal
AU - Hanci, Volkan
AU - Çağlayan, Çiğdem
AU - Kahveci, Ferda
AU - Demirağ, Kubilay
AU - Baydemir, Canan
AU - Ünal, Necmettin
AU - Özdemir, Pinar
AU - Ulusoy, Hülya
AU - Memis, Dilek
AU - Arar, Cavidan
AU - Yilmaz, Elif
AU - Çelik, Melek
AU - Cinel, Ismail
AU - Temur, Sibel
AU - Yasar, Mehmet Akif
AU - Çulha, Hamdiye Tutan
AU - Balci, Canan
AU - San, Sultan
AU - Salbes, Asena
AU - Özkan, Elçin
AU - Palabiyik, Onur
AU - Çelik, Jale
AU - Yosunkaya, Alper
AU - Çiçekçi, Faruk
AU - Özkoçak, Isil
AU - Kati, Ismail
AU - Basar, Hülya
AU - Turan, Sema
AU - Ünver, Süheyla
AU - Büyükkoçak, Ünase
AU - Akin, Aynur
AU - Gürsoy, Sinan
AU - Tok, Demet
AU - Serin, Simay
AU - Kiter, Seda Dursun
AU - Dogan, Hakan
AU - Oruç, Abdülkadir
AU - Balaban, Onur
AU - Tüfek, Dilara
AU - Kurt, Ibrahim
AU - Bilgi, Murat
AU - Tuna, Verda
AU - Özkök, Aysegül
AU - Sen, Ahmet
AU - Tas, Nilay
AU - Ayoglu, Hilal
AU - Arslantas, Reyhan
N1 - Publisher Copyright:
© 2018 The Author(s).
PY - 2018/4/16
Y1 - 2018/4/16
N2 - Background: The prevalence and mortality of sepsis are largely unknown in Turkey, a country with high antibiotic resistance. A national, multicenter, point-prevalence study was conducted to determine the prevalence, causative microorganisms, and outcome of sepsis in intensive care units (ICUs) in Turkey. Methods: A total of 132 ICUs from 94 hospitals participated. All patients (aged > 18 years) present at the participating ICUs or admitted for any duration within a 24-h period (08:00 on January 27, 2016 to 08:00 on January 28, 2016) were included. The presence of systemic inflammatory response syndrome (SIRS), severe sepsis, and septic shock were assessed and documented based on the consensus criteria of the American College of Chest Physicians and Society of Critical Care Medicine (SEPSIS-I) in infected patients. Patients with septic shock were also assessed using the SEPSIS-III definitions. Data regarding demographics, illness severity, comorbidities, microbiology, therapies, length of stay, and outcomes (dead/alive during 30 days) were recorded. Results: Of the 1499 patients included in the analysis, 237 (15.8%) had infection without SIRS, 163 (10.8%) had infection with SIRS, 260 (17.3%) had severe sepsis without shock, and 203 (13.5%) had septic shock. The mortality rates were higher in patients with severe sepsis (55.7%) and septic shock (70.4%) than those with infection alone (24.8%) and infection + SIRS (31.2%) (p < 0.001). According to SEPSIS-III, 104 (6.9%) patients had septic shock (mortality rate, 75.9%). The respiratory system (71.6%) was the most common site of infection, and Acinetobacter spp. (33.7%) were the most common isolated pathogen. Approximately, 74.9%, 39.1%, and 26.5% of Acinetobacter, Klebsiella, and Pseudomonas spp. isolates, respectively, were carbapenem-resistant, which was not associated with a higher mortality risk. Age, acute physiology and chronic health evaluation II score at ICU admission, sequential organ failure assessment score on study day, solid organ malignancy, presence of severe sepsis or shock, Candida spp. infection, renal replacement treatment, and a nurse-to-patient ratio of 1:4 (compared with a nurse-to-patient ratio of 1:2) were independent predictors of mortality in infected patients. Conclusions: A high prevalence of sepsis and an unacceptably high mortality rate were observed in Turkish ICUs. Although the prevalence of carbapenem resistance was high in Turkish ICUs, it was not associated with a higher risk for mortality.
AB - Background: The prevalence and mortality of sepsis are largely unknown in Turkey, a country with high antibiotic resistance. A national, multicenter, point-prevalence study was conducted to determine the prevalence, causative microorganisms, and outcome of sepsis in intensive care units (ICUs) in Turkey. Methods: A total of 132 ICUs from 94 hospitals participated. All patients (aged > 18 years) present at the participating ICUs or admitted for any duration within a 24-h period (08:00 on January 27, 2016 to 08:00 on January 28, 2016) were included. The presence of systemic inflammatory response syndrome (SIRS), severe sepsis, and septic shock were assessed and documented based on the consensus criteria of the American College of Chest Physicians and Society of Critical Care Medicine (SEPSIS-I) in infected patients. Patients with septic shock were also assessed using the SEPSIS-III definitions. Data regarding demographics, illness severity, comorbidities, microbiology, therapies, length of stay, and outcomes (dead/alive during 30 days) were recorded. Results: Of the 1499 patients included in the analysis, 237 (15.8%) had infection without SIRS, 163 (10.8%) had infection with SIRS, 260 (17.3%) had severe sepsis without shock, and 203 (13.5%) had septic shock. The mortality rates were higher in patients with severe sepsis (55.7%) and septic shock (70.4%) than those with infection alone (24.8%) and infection + SIRS (31.2%) (p < 0.001). According to SEPSIS-III, 104 (6.9%) patients had septic shock (mortality rate, 75.9%). The respiratory system (71.6%) was the most common site of infection, and Acinetobacter spp. (33.7%) were the most common isolated pathogen. Approximately, 74.9%, 39.1%, and 26.5% of Acinetobacter, Klebsiella, and Pseudomonas spp. isolates, respectively, were carbapenem-resistant, which was not associated with a higher mortality risk. Age, acute physiology and chronic health evaluation II score at ICU admission, sequential organ failure assessment score on study day, solid organ malignancy, presence of severe sepsis or shock, Candida spp. infection, renal replacement treatment, and a nurse-to-patient ratio of 1:4 (compared with a nurse-to-patient ratio of 1:2) were independent predictors of mortality in infected patients. Conclusions: A high prevalence of sepsis and an unacceptably high mortality rate were observed in Turkish ICUs. Although the prevalence of carbapenem resistance was high in Turkish ICUs, it was not associated with a higher risk for mortality.
KW - Carbapenem resistance
KW - Intensive care
KW - Point prevalence
KW - Sepsis
KW - Turkey
UR - http://www.scopus.com/inward/record.url?scp=85045412181&partnerID=8YFLogxK
U2 - 10.1186/s13054-018-2013-1
DO - 10.1186/s13054-018-2013-1
M3 - Article
C2 - 29656714
AN - SCOPUS:85045412181
SN - 1364-8535
VL - 22
JO - Critical Care
JF - Critical Care
IS - 1
M1 - 93
ER -